EPO and Miyoshi myopathy: Typically, patients with advanced chronic kidney disease will receive EPO at 50-100 IU/Kg three times a week, and patients with hematological malignancies (MDS, MM) will start with higher doses, i.e., 150 IU/Kg three times a week or 40,000 IU once a week.